Pickhardt M - Search Results

1

On the way to precision formulation additives: 2D-screening to select solubilizers with tailored host and release capabilities.

Remmler D, Schwaar T, Pickhardt M, Donth C, Mandelkow E, Weller MG, Börner HG. Remmler D, et al. Among authors: pickhardt m. J Control Release. 2018 Sep 10;285:96-105. doi: 10.1016/j.jconrel.2018.06.032. Epub 2018 Jun 28. J Control Release. 2018. PMID: 29964137

2

Inhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell Viability.

Pickhardt M, Lawatscheck C, Borner HG, Mandelkow E. Pickhardt M, et al. Curr Alzheimer Res. 2017;14(7):742-752. doi: 10.2174/1567205014666170202103136. Curr Alzheimer Res. 2017. PMID: 28155596

3

Gaining Insights into Specific Drug Formulation Additives for Solubilizing a Potential Anti-Alzheimer Disease Drug B4A1.

Lawatscheck C, Pickhardt M, Grafl A, Linkert K, Polster F, Mandelkow E, Börner HG. Lawatscheck C, et al. Among authors: pickhardt m. Macromol Biosci. 2017 Oct;17(10). doi: 10.1002/mabi.201700109. Epub 2017 May 10. Macromol Biosci. 2017. PMID: 28488401

4

Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds.

Lawatscheck C, Pickhardt M, Wieczorek S, Grafmüller A, Mandelkow E, Börner HG. Lawatscheck C, et al. Among authors: pickhardt m. Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8752-6. doi: 10.1002/anie.201601147. Epub 2016 Jun 10. Angew Chem Int Ed Engl. 2016. PMID: 27282127

5

Progress and developments in tau aggregation inhibitors for Alzheimer disease.

Bulic B, Pickhardt M, Mandelkow E. Bulic B, et al. Among authors: pickhardt m. J Med Chem. 2013 Jun 13;56(11):4135-55. doi: 10.1021/jm3017317. Epub 2013 Mar 13. J Med Chem. 2013. PMID: 23484434 Review.

6

Screening of a neuronal cell model of tau pathology for therapeutic compounds.

Pickhardt M, Tassoni M, Denner P, Kurkowsky B, Kitanovic A, Möhl C, Fava E, Mandelkow E. Pickhardt M, et al. Neurobiol Aging. 2019 Apr;76:24-34. doi: 10.1016/j.neurobiolaging.2018.11.026. Epub 2018 Dec 13. Neurobiol Aging. 2019. PMID: 30640040

7

Tau protein and tau aggregation inhibitors.

Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E. Bulic B, et al. Among authors: pickhardt m. Neuropharmacology. 2010 Sep-Oct;59(4-5):276-89. doi: 10.1016/j.neuropharm.2010.01.016. Epub 2010 Feb 10. Neuropharmacology. 2010. PMID: 20149808 Review.

8

Time course of Tau toxicity and pharmacologic prevention in a cell model of Tauopathy.

Pickhardt M, Biernat J, Hübschmann S, Dennissen FJA, Timm T, Aho A, Mandelkow EM, Mandelkow E. Pickhardt M, et al. Neurobiol Aging. 2017 Sep;57:47-63. doi: 10.1016/j.neurobiolaging.2017.04.022. Epub 2017 May 3. Neurobiol Aging. 2017. PMID: 28600952

9

Structural Basis of Small Molecule Targetability of Monomeric Tau Protein.

Kiss R, Csizmadia G, Solti K, Keresztes A, Zhu M, Pickhardt M, Mandelkow E, Tóth G. Kiss R, et al. Among authors: pickhardt m. ACS Chem Neurosci. 2018 Dec 19;9(12):2997-3006. doi: 10.1021/acschemneuro.8b00182. Epub 2018 Jul 16. ACS Chem Neurosci. 2018. PMID: 29944336

10

"Lest we forget you--methylene blue...".

Schirmer RH, Adler H, Pickhardt M, Mandelkow E. Schirmer RH, et al. Among authors: pickhardt m. Neurobiol Aging. 2011 Dec;32(12):2325.e7-16. doi: 10.1016/j.neurobiolaging.2010.12.012. Epub 2011 Feb 12. Neurobiol Aging. 2011. PMID: 21316815 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page